Experimental Gene Therapy Showed Promising Safety and Efficacy in Primate Study of Late-Infantile Batten Disease
source: shutterstock.com

Experimental Gene Therapy Showed Promising Safety and Efficacy in Primate Study of Late-Infantile Batten Disease

Children with late-infantile onset Batten disease (CLN2) may be treated with an enzyme replacement therapy (ERT). However, this therapy cannot reverse the damage or progression children have already experienced. Researchers…

Continue Reading Experimental Gene Therapy Showed Promising Safety and Efficacy in Primate Study of Late-Infantile Batten Disease
Auditory Sensory Memory System Decline: A Potential Neuromarker for Juvenile-Onset Batten Disease
geralt / Pixabay

Auditory Sensory Memory System Decline: A Potential Neuromarker for Juvenile-Onset Batten Disease

In total, there are thirteen subtypes of Batten disease. Batten disease, also known as neuronal ceroid lipofuscinosis (NCL), is a rare and inherited neurodegenerative disorder that causes visual impairment, behavioral…

Continue Reading Auditory Sensory Memory System Decline: A Potential Neuromarker for Juvenile-Onset Batten Disease

A New Collaboration Could Bring A New CLN2 Batten Disease Treatment To Patients Faster

LEXEO Therapeutics and FUJIFILM Diosynth Biotechnologies have just announced their collaborative partnership. The aim is to develop and ultimately manufacture the AAV-mediated gene therapies developed by LEXEO. LEXEO LEXEO is…

Continue Reading A New Collaboration Could Bring A New CLN2 Batten Disease Treatment To Patients Faster
Two Fathers of Daughters with Batten Disease Created a Bill Which Would Fund Genetic Testing
source: pixabay.com

Two Fathers of Daughters with Batten Disease Created a Bill Which Would Fund Genetic Testing

Mike Jackson's young daughter Evelyn was diagnosed with Batten disease after a neurologist suggested a genetic test which the family could take for free. John Barclay's daughter River passed away…

Continue Reading Two Fathers of Daughters with Batten Disease Created a Bill Which Would Fund Genetic Testing
Free Genetic Testing for Lysosomal Storage Diseases Provided by Invitae, Axovant
source: pixabay.com

Free Genetic Testing for Lysosomal Storage Diseases Provided by Invitae, Axovant

  According to Batten Disease News, Invitae and Axovant Gene Therapies partnered up to offer free genetic testing in North America. This will focus on children who are thought to…

Continue Reading Free Genetic Testing for Lysosomal Storage Diseases Provided by Invitae, Axovant
It Just Makes “Antisense:” Using Genetic Medicine to Treat Rare Diseases
source: pixabay.com

It Just Makes “Antisense:” Using Genetic Medicine to Treat Rare Diseases

  As previously published in Scientific American, slightly after her first birthday, Emma Larson lost the use of her legs and started experiencing difficulty crawling. She was diagnosed with spinal muscular…

Continue Reading It Just Makes “Antisense:” Using Genetic Medicine to Treat Rare Diseases
Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases
source: pixabay.com

Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases

Patients with congenital diseases often experience a range of uncomfortable symptoms. On one side of the world, a family with erythromelalgia, a painful condition which can cause redness and swelling…

Continue Reading Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases
Neurogene and Behind the Seizure Work to Provide Better Diagnostics for Batten Disease
source: pixabay.com

Neurogene and Behind the Seizure Work to Provide Better Diagnostics for Batten Disease

Neurogene, which works to provide treatments for rare neurological disorders, has recently joined with Behind the Seizure. Behind the Seizure was established by two other companies, BioMarin and Invitae, with…

Continue Reading Neurogene and Behind the Seizure Work to Provide Better Diagnostics for Batten Disease